和铂医药宣布与兰纳成达成长期战略合作协议,双方将整合各自技术优势,共同致力于新一代放射性核素药物偶联物的研发与商业化进程。此次合作旨在突破现有技术瓶颈,通过创新疗法为肿瘤治疗领域提供更精准的解决方案。
和铂医药宣布与兰纳成达成长期战略合作协议,双方将整合各自技术优势,共同致力于新一代放射性核素药物偶联物的研发与商业化进程。此次合作旨在突破现有技术瓶颈,通过创新疗法为肿瘤治疗领域提供更精准的解决方案。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.